Search Result "melanocortin receptors (mc1 and 3-r)"
Melanocortin Receptor Type 3 as a Potential Target for Anti-Inflammatory Therapy
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3 Issue: 3 Year: 2004 Page: 311-315
Author(s): Connie W. Lam, Stephen J. Getting
Melanocortin-4 Receptor Antagonists for the Treatment of Depression and Anxiety Disorders
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1145-1151
Author(s): Taketoshi Okubo, Shigeyuki Chaki
Melanocortin Receptors as Drug Targets for Disorders of Energy Balance
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5 Issue: 3 Year: 2006 Page: 251-261
Author(s): Roger A.H Adan, Gertjan v. Dijk
Molecular Modeling of Melanocortin Receptors
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1042-1051
Author(s): Hongmao Sun, David Fry
Neuroprotective Effects of Melanocortins in CNS Injury
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1929-1941
Author(s): H. S. Sharma, T. Lundstedt, M. Flardh, A. Skottner, L. Wiklund
Progress in the Development of Melanocortin Receptor Selective Ligands
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 3443-3479
Author(s): Boman G. Irani, Jerry R. Holder, Aleksandar Todorovic, Andrzej M. Wilczynski, Christine G. Joseph, Krista R. Wilson, Carrie Haskell-Luevano
Studies on the Structure-Activity Relationship of the Basic Amine of Phenylpiperazines as Melanocortin-4 Receptor Antagonists
Journal: Medicinal Chemistry
Volume: 4 Issue: 1 Year: 2008 Page: 67-74
Author(s): Chen Chen, Joe A. Tran, Melissa Arellano, Beth A. Fleck, Joseph Pontillo, Dragan Marinkovic, Fabio C. Tucci, Jenny Wen, John Saunders
Melanocortin-4 Receptor Antagonists as Potential Therapeutics in the Treatment of Cachexia
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1131-1136
Author(s): Alan C. Foster, Chen Chen
Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 6 Year: 2013 Page: 735-750
Author(s): S. Leone,G. Noera,A. Bertolini
Modulation of γ2-MSH Hepatoprotection by Antisense Peptides and Melanocortin Subtype 3 and 4 Receptor Antagonists
Journal: Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2015 Page: 286-295
Author(s): Petra Turcic, Nikola Stambuk, Pasko Konjevoda, Tomislav Kelava, Mario Gabricevic, Ranko Stojkovic, Gorana Aralica